Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/108
Title: | Prevalence of excessive tearing in women with early breast cancer receiving adjuvant Docetaxel-based chemotherapy. |
Epworth Authors: | De Boer, Richard |
Other Authors: | Chan, Arlene Su, Charles Gajdatsy, Adam |
Keywords: | Oncology Breast Cancer Breast Neoplasms Drug Therapy-docetaxel Chemotherapy Adjuvants, Pharmaceutic Excessive Tearing |
Issue Date: | Jun-2013 |
Citation: | J Clin Oncol. 2013 Jun 10;31(17):2123-7. |
Abstract: | PURPOSE: To define the incidence and impact of tearing in patients receiving adjuvant docetaxel-based chemotherapy and assess for lacrimal duct obstruction (LDO) as a causative factor. PATIENTS AND METHODS: Consecutive patients with early breast cancer recommended for docetaxel-based chemotherapy with no prior ocular symptoms were included. Before and after completion of chemotherapy, patients underwent lacrimal drainage evaluation by computed tomographic dacrocystography (CT-DCG) and ophthalmic assessment. Eye symptoms were assessed at baseline, during, and after completion of chemotherapy. |
URI: | http://hdl.handle.net/11434/108 |
DOI: | doi: 10.1200/JCO.2012.45.6574. |
PubMed URL: | http://www.ncbi.nlm.nih.gov/pubmed/23650421 |
ISSN: | 1527-7755 |
Journal Title: | Journal of Clinical Oncology. |
Type: | Journal Article Text |
Affiliated Organisations: | Curtin University and Mount Hospital, Australia. Medical Oncology, Epworth Hospital, Australia. |
Type of Clinical Study or Trial: | Observational prospective study. |
Appears in Collections: | Cancer Services |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.